دورية أكاديمية

Comparative toxicity and toxicokinetic studies of oxiracetam and (S)-oxiracetam in dogs.

التفاصيل البيبلوغرافية
العنوان: Comparative toxicity and toxicokinetic studies of oxiracetam and (S)-oxiracetam in dogs.
المؤلفون: Liu, Tian-tian, Wei, Jin-feng, Wang, Ai-ping, Jin, Hong-tao, Guo, Xin-miao, Ye, Xiang-feng, Rong, Zu-yuan
المصدر: Xenobiotica; Sep2019, Vol. 49 Issue 9, p1054-1062, 9p
مصطلحات موضوعية: COGNITION disorders, DOGS
مستخلص: Oxiracetam (ORT) is known as a derivative of piracetam in the family of nootropics for treating memory impairment and cognition disorders. Given the chiral toxicological concerns surrounding ORT and the absence studies of (S)-ORT, the toxicity and toxicokinetics of (S)-ORT, and comparative toxicology of oxiracetam were systematically investigated in dogs following acute and 13-week repeated oral dosing. The animal toxicity mainly manifested as loose stools in both the acute and the 13-week studies. The no-observed-adverse-effect level is proposed to be 100 mg/kg. The 13-week toxicokinetics study indicated that, in the (S)-ORT group, the time to peak concentration was delayed, elimination half-life extended, and apparent volume of distribution increased compared with the ORT group. The clearance rate increased at low- and mid-doses, but decreased in the high-dose group and was accompanied by drug accumulation. Compared with the same dose of ORT, (S)-ORT had a lower clearance rate and longer elimination half-life. [ABSTRACT FROM AUTHOR]
Copyright of Xenobiotica is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00498254
DOI:10.1080/00498254.2018.1528027